Discover Great Companies Discover Great Clients
Popularity  1.3万   |   Followers  3   |   Feedback  3 Claim this company
No.337 Changping District Popularity Ranking Beijing No.11 Teng Tong Zhi Liao No.14 Antibiotics No.14 Pharmaceutical R&D No.14 Xin Xue Guan Yao Healthcare Supplies Medical Products Zhi Yao / Yao Industries Medical Devices Pharmaceutical Pharmaceutical Industrial Xue Guan Zhi Liao Ping Sheet 中关村高新技术企业 高新技术企业 省级高新技术企业 市级高新技术企业 GMP认证
More

Company Overview

  • Nature: Private Enterprise Size: 100-499 employees Founded: 28年
  • Industry: Pharmaceutical/Biotechnology
  • Full name: Lepu Pharmaceutical (Beijing) Co., Ltd.。

Development Stage

  • Honors: 中关村高新技术企业 高新技术企业 According to algorithm
  • Salary: 63.7% of positions earn 3-6K, In 2026 vs last yearremained flat.。.
  • Recruiting: In 2026 vs 2025decreased by 11%.
  • Requirement: Education: 大专 leads with 54.5%. Experience: 不限 leads with 54.5%.
  • Region: Distributed across 1 regions, 北京: 100%.

About the Company

Lepu Pharmaceutical (Beijing) Co., Ltd. (hereinafter referred to as Lepu Pharmaceutical (Beijing) Company) is a controlling subsidiary of the pharmaceutical segment of Lepu Medical Technology (Beijing) Co., Ltd. (hereinafter referred to as Lepu Medical). The company was restructured and established on the basis of the acquisition of Beijing Yongzheng Pharmaceutical Co., Ltd. (hereinafter referred to as Yongzheng Pharmaceutical). Its predecessor, Yongzheng Pharmaceutical, was founded in 1998 and is a modern pharmaceutical enterprise integrating drug research and development, production, and sales. The company is located in Baishan Town, Changping District, where the air is fresh and transportation is convenient. It is 3.5 kilometers west of the Badaling Expressway and Shahe University Town, and 2.5 kilometers east of Xiaotangshan, the home of hot springs. It covers an area of 98 mu, with a greening area of 40%, making it a garden-style enterprise with a beautiful environment. As one of the first pharmaceutical enterprises in Beijing to pass the new version of GMP certification, the company has 35 varieties in three dosage forms: tablets, granules, and capsules. The antipyretic-analgesic product "Surong-Nimesulide Dispersible Tablets", as the company's flagship product, firmly occupies the * camp. "Amlodipine Besylate Tablets" and "Isosorbide Mononitrate Tablets" are products highly compatible with Lepu Medical's cardiovascular medical devices, and are also mature and classic cardiovascular drugs. With the gradual integration of the market, sales are expected to soar. Lepu Medical is the parent company of Lepu Pharmaceutical (Beijing) Company. It is a large-scale manufacturing enterprise of cardiovascular interventional medical products controlled by a central state-owned enterprise, jointly funded by the 725th Research Institute of China Shipbuilding Industry Corporation and the American WP Company. It is one of the first 28 enterprises listed on the ChiNext Board of the Shenzhen Stock Exchange in 2009, and in November 2014 it was selected as one of the 50 sample stocks of the CCTV Finance 50 Index for 2014. As a * enterprise in the cardiovascular medical device industry, Lepu Medical has further broadened its related fields and product lines in cardiovascular treatment through vigorous mergers and acquisitions in the pharmaceutical field, enhancing the overall brand influence of Lepu Medical in the cardiovascular medical field. The asset acquisition and restructuring with Yongzheng Pharmaceutical can be described as a model of integration with complementary advantages and resource sharing between the two parties. Relying on Lepu Medical's diversified industrial development platform and years of industry accumulation, the newly established Lepu Pharmaceutical (Beijing) Company will be like a tiger with wings, reaching new levels and scaling new heights in the field of pharmaceutical preparation and research and development. Lepu Pharmaceutical (Beijing) Company will continue to follow the business philosophy of "making quality medicines and building a quality enterprise". Under the new strategic pattern, it has clearly defined new positioning and work priorities: "ensure supply, ensure quality"; "ensure safety, control costs"; "respond to regulations, standardize and upgrade". It will further strengthen system construction, process construction, and team building, effectively integrate into Lepu Medical's advanced management concepts and mechanisms, and make due contributions to the implementation of Lepu Medical's strategic goals. Employment principle—"person-enterprise match, person-post match"; talent is the company's * resource! Team style—a team with a high sense of responsibility, mission, integrity, and vitality!

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (4 open positions)

Manage
Note: How fast is hiring at Lepu Pharmaceutical (Beijing) Co., Ltd. growing? 2026: 8 openings (down 11%), 2025: 9 openings (up 350%), 2024: 2 openings (up 100%), 2023: 1 openings (flat), 2022: 1 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

— What Are the Salaries Like? (11 records)

Manage
salary range: 3K - 10K, 63.7% of roles pay ¥3-6K
Note: salary statistics are based on 11 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Lepu Pharmaceutical (Beijing) Co., Ltd.?63.7% of positions earn 3-6K, Undergraduate salary: ¥。在校学生类 average salary ¥4.5K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Job Category

  • 在校学生类
    36.4% of total 36.4%
  • 技工类
    36.4% of total 36.4%
  • 人力资源类
    18.2% of total 18.2%
  • 质量管理类
    18.2% of total 18.2%

Education

  • 大专
    54.5% of total 54.5%
  • 不限
    36.4% of total 36.4%
  • 本科
    9.1% of total 9.1%

Experience

  • 不限
    54.5% of total 54.5%
  • 1-3年
    27.3% of total 27.3%
  • 3-5年
    9.1% of total 9.1%
  • 5-10年
    9.1% of total 9.1%
View Detailed Analysis

What does Lepu Pharmaceutical (Beijing) Co., Ltd. require? Who is Lepu Pharmaceutical (Beijing) Co., Ltd. hiring? recruitment: 在校学生类占比最多占36.4%,其次是技工类占36.4%. What education can get in at ? 大专占比最多占54.5%,其次是不限占36.4%. Work experience required at ? 不限占比最多占54.5%,其次是1-3年占27.3%. Where are the job locations at ? 北京占比最多占100%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 3,826.6667万(元)
Legal Representative: 郭欲晓
Date Established:
Credit Code: 91110114634394670K
Registered Address: 北京市昌平区科技园区超前路9号B座2032

People who follow this company also follow

Competitors (Similar Companies)

“A comprehensive large-scale pharmaceutical enterprise integrating new ”
知识产权代理 律师事务所/法律服务 商标申请 商标事务所
新材料 聚乙烯/PE 化工/化学 塑料合金
精密机械零部件 机械零部件 生产 机械五金加工
服装/服饰 纺织 丝绸 化纤面料
工程设计 建筑幕墙 机电设备安装 门窗
环保/节能 品牌策划 环保科技/技术 艺术涂料
离心泵 多级离心泵 自动化 生产
安全设备 呼吸防护设备 生产 安全防护
开关电源 变电站 直流/DC电源 电力
造纸/造纸厂/纸业 打印纸 文化用纸 双面胶
模具 模具设计 模具开发 硅胶
塑胶零件 塑胶零配件 眼镜 配件
电机/电动机 压缩机 制冷 制冷设备
跨境服务 金融 移动支付 电子商务

Discover Great Companies, Discover Great Clients

北京公司名录 北京“Changping District”公司名录 北京“抗生素”公司名录 北京“医疗器械”公司名录 北京“药品研发”公司名录 北京“医用产品”公司名录 北京“医疗用品”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates